BEKE vs EQR

BEKE's deterministic health scores signal significant distress: the Piotroski F-Score of 3/9 indicates weak financial health, with deteriorating profitability and negative earnings growth. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given the company's declining earnings and high payout ratio. While the Graham Number ($9.15) suggests undervaluation, the current price of $16.90 trades at a substantial premium, reflecting overoptimistic growth expectations. Analysts recommend 'buy' with a target of $20.68, but this is inconsistent with the company's weak fundamentals and negative earnings trajectory. The stock has underperformed over multiple time horizons, including a 5-year decline of 73.3%.

Equity Residential (EQR) presents a concerning valuation profile, with a Piotroski F-Score of 4/9 indicating only stable health and a current price of $62.26 that significantly exceeds both its Graham Number ($43.93) and Intrinsic Value ($20.58). While the company maintains strong profit margins and a manageable debt-to-equity ratio, it is plagued by declining earnings growth (-8.80% YoY) and a consistent track record of missing analyst estimates. The forward P/E expansion to 41.69 suggests a projected contraction in earnings, while a 94.35% dividend payout ratio leaves virtually no margin for error. Combined with bearish insider selling and a 0/100 technical trend, the stock appears fundamentally overpriced.